You don't have to be a great clinician to be a biotech CEO, but if you're not a great clinician, best you stay out of the lab.
Similarly, you don't have to be a great publicist to be a biotech CEO, but if you're not a great publicist, best you stay away from the cameras.
Try to understand the post before resorting to insults and dummy spits.
The idea of the Fishburne video and interviews like the Andrew Scott one are to attract investors and potential suitors. I've provided some objective material as to why LC's approach is less than ideal. No one should invest in a company without deeper research than an interview with the CEO, but a CEO that presents poorly may discourage an investor from doing the research in the first place (given the plethora of investment opportunities).
You don't have to be a great clinician to be a biotech CEO, but...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.246M | 14.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 446526 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 535664 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |